BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2001
View Archived Issues
NPY antagonist no longer in development at AstraZeneca
Read More
Patient enrollment complete in Spheramine trial for Parkinson's disease
Read More
Orphan Medical provides update on drugs nearing approval
Read More
ACE inhibitor introduced in U.S. for reducing cardiovascular events in patients at risk
Read More
CAT and Elan to develop human antibodies for neurological diseases
Read More
Evidence for use of lamotrigine in the control of neuropathic pain presented
Read More
Selective aromatase inhibitors show promise in early or preventive breast cancer treatment
Read More
Pharmacopeia and Amgen enter two new drug discovery collaborations
Read More
Genomics-based collaboration established by ImmunoGen and Avalon
Read More
Feasibility study commences for Medusa-delivered relaxin
Read More
TC-2559: a neuronal nicotinic receptor ligand expected to have negligible peripheral effects
Read More
Tamiflu to be launched this week in Japan
Read More
Clinical trials begin in Nairobi with first AIDS vaccine designed for Africa
Read More
Phase II results with rFGF-2 in PAD reported
Read More
Rivastigmine emerges from recent study as effective and safe therapy for Lewy body dementia
Read More
Morphine alternative M6G shows promise in phase II trial
Read More
Higher dose Neurontin tablets now cleared for use in Rx of neuropathic pain
Read More
Antisoma's TheraFab enters phase I lung cancer trial
Read More
Amgen highlights Q4 and full-year 2000 developments
Read More
Isoquinolines as inhibitors of If current for cardiovascular disorders
Read More
Novel treatments for pain and inflammation identified at Novartis
Read More
Antiapoptotic agents designed by Elan provide significant protection in stroke model
Read More
New isocoumarins with antiangiogenic activity claimed by Korean scientists
Read More
Somatostatin and neuromedin B receptor agonists and their use
Read More
Merck discloses two series of thrombin inhibitors in recent patents
Read More
Additional carcinogenicity studies requested by FDA to support Pozen's MT-100 NDA
Read More
MMP-13 inhibitors particularly useful for arthritis, atherosclerosis, as claimed by AstraZeneca
Read More
NMDA receptor antagonism may be involved in neuroprotective effects of mglu5 antagonists
Read More
